We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Novel Microbes Identified, Linked to Severe Diarrhea

By LabMedica International staff writers
Posted on 09 Jul 2014
Print article
454 Life Sciences Genome Sequencer FLX system
454 Life Sciences Genome Sequencer (Photo courtesy of Roche Diagnostics)
Microorganisms have been identified that may trigger diarrheal disease and others that may protect against it, which were not widely linked to the condition previously.

Diarrheal diseases continue to contribute significantly to morbidity and mortality in infants and young children in developing countries and there is an urgent need to better understand the contributions of novel, potentially uncultured, diarrheal pathogens to severe diarrheal disease, as well as distortions in normal gut microbiota composition that might facilitate severe disease.

An international team of scientists led by those at the University of Maryland (College Park, MD, USA) surveyed the intestinal microbiota of 992 children from four under-developed countries in West Africa (The Gambia and Mali), East Africa (Kenya), and South Asia (Bangladesh). Stool samples were selected from a large case/control study of moderate-to-severe diarrhea in children aged less than five years. All samples were analyzed by traditional microbiological tests for known bacterial, viral, and eukaryotic pathogens.

DNA was isolated and extracted using the QIAamp DNA stool extraction kit (Qiagen; Venlo, The Netherlands). DNA was amplified using “universal” primers targeting the V1-V2 region of the 16S ribosomal ribonucleic acid (rRNA) gene, a small subunit of the ribosome, in bacteria. Both forward and reverse primers had a 5’ portion specific for use with FLX sequencing technology (454 Life Sciences; Branford, CT, USA).

The scientists identified statistically significant disease associations with several organisms already implicated in diarrheal disease, such as members of the Escherichia/Shigella genus and Campylobacter jejuni. They also found that organisms not widely believed to cause the disease, including Streptococcus and Granulicatella, correlated with the condition in their study. In addition, the study revealed that the Prevotella genus and Lactobacillus ruminis may play a protective role against diarrhea. In almost 50% of the children examined with diarrhea, the condition could not be attributed to a specific causal pathogen. The team also found numerous children carrying Shigella, which is known to cause problems, yet the children showed no signs of moderate to severe diarrhea.

The authors concluded that their analysis of the 16S rRNA gene-based taxonomic profile of diarrheal and control stool samples demonstrated a strong association between acute diarrheal disease and the overall taxonomic composition of the stool microbiota in young children from the developing world. O. Colin Stine, PhD, a professor and senior author of the study said, “We were able to identify interactions between microbiota that were not previously observed, and we think that some of those interactions may actually help prevent the onset of severe diarrhea.” The study was published on June 27, 2014, in the journal Genome Biology.

Related Links:

University of Maryland
454 Life Sciences


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.